Graft Enhancement, Immunologic

Overview

The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Graft Enhancement, Immunologic

Topic type

Treatment

Category

Therapy

MeSH classification

E02.095.465.425.450.440|E05.478.610.500

Questions to ask about Graft Enhancement, Immunologic

• What outcome should I realistically expect?
• How many appointments or sessions may be needed?
• Are there alternative treatment options?
• What are the possible risks or side effects?
• What follow-up care may be required?

Finding care related to Graft Enhancement, Immunologic

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.